Effect of modulation of the transferrin receptor on gallium-67 uptake and cytotoxicity in lymphoma cell lines
1996

Gallium-67 Uptake and Cytotoxicity in Lymphoma Cells

publication Evidence: moderate

Author Information

Author(s): AE van Leeuwen-Stokl, GJ Schuurhuis, AM Dräger, AWJ Visser-Platier, GJJ Teule, PC Huijgens

Primary Institution: Free University Hospital, Amsterdam, The Netherlands

Hypothesis

Can the expression of the transferrin receptor be modulated to increase gallium-67 uptake in lymphoma cell lines?

Conclusion

Priming lymphoma cells with cytostatic drugs increases transferrin receptor expression and gallium-67 uptake, leading to an additive effect on clonogenic capacity.

Supporting Evidence

  • All three drugs induced an increase in S-phase content, transferrin receptor expression, and gallium-67 uptake in U937 and U715 cells.
  • Preincubation with Ara-C, hydroxyurea, and methotrexate resulted in statistically significant increases in S-phase cells.
  • Clonogenic capacity after gallium-67 treatment was lower than expected, indicating an additive effect rather than a synergistic one.

Takeaway

This study found that using certain cancer drugs can help lymphoma cells take in more gallium-67, which might help in treating cancer.

Methodology

The study examined the effects of cytostatic drugs on transferrin receptor expression and gallium-67 uptake in U937 and U715 lymphoma cell lines using both single cells and multicellular spheroids.

Limitations

The increases in transferrin receptor expression and gallium-67 uptake were less than expected, and the study used suboptimal drug concentrations to avoid excessive cell death.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication